EFFECT OF NON-VOLATILE SOLVENT AND EXCIPIENT RATIO ON FLOW AND CONSOLIDATION PROPERTIES OF POWDER BLEND FOR LIQUISOLID COMPACTS
Objective: To study the effect of non-volatile solvent and excipient ratio on flow and consolidation properties of powder blend for liquisolid compacts.
Methods: The effect of non-volatile solvent and excipient ratio on flow and consolidation properties of powder blend for liquisolid compacts was studied. Tween 20, microcrystalline cellulose and colloidal silicon dioxide were selected as non-volatile solvent, carrier and coating material respectively. A central composite statistical design with 2 factors, 5 levels, and 13 runs was selected for the study. Quantity of Tween 20 and excipient ratio were selected as independent factors and an angle of repose, Carrâ€™s index and Hausner ratio were selected as responses indicative of flow and consolidation properties.
Results: From the statistical analysis of the data obtained for an angle of repose it was found that the quadratic model was not significant. The response surface quadratic models obtained for Carrâ€™s index and Hausner ratio were found to be significant. Both responses were much influenced by the quantity of non-volatile solvent than the excipient ratio. Both the independent factors were observed to have interaction. But the interactions were statistically insignificant.
Conclusion: The selected independent factors were found to be influential on flow and consolidation properties of powder blend for liquisolid compacts. The results of this study could be used for selection of appropriate systems for the preparation of liquisolid blends with tailored flow and consolidation properties.
2. Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablet formulation: In vitro and In vivo Evaluation. Eur J Pharm Biopharm 2008;69:993-1003.
3. Ghorab MM, Salam HM, EL-Sayad MA. Tablet formulation containing meloxicam and Î²-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004;5:1-6.
4. Grover R, Spireas S, Wang T. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev Ind Pharm 1999;25:163-8.
5. Gubbi S, Ravindra J. Liquisolid technique for enhancement of dissolution properties of bromhexine hydrochloride. Res J Pharm Tech 2009;2:382-6.
6. Javadzadeh Y, Musaalrezaei L, Nokhodchi A. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int J Pharm 2008;362:102â€“8.
7. Javadzadeh Y, Shariati H, Movahhed-Danesh E, Nokhodchi A. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm 2009;35:243-51.
8. Patel T, Patel LD, Suhagia BN, Soni T, Patel T. Formulation of fenofibrate liquisolid tablets using central composite design. Curr Drug Delivery 2014;11:11-23.
9. Vittal GV, Deveswaran R, Bharath S, Basavaraj B, Madhavan V. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design. Int J Pharm Invest 2012;2:150-6.
10. Prajapati ST, Bulchandani HH, Patel DM, Dumaniya SK, Patel CN. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil. J Drug Delivery 2013. doi.org/ 10.1155/2013/870579. [Article in Press].